Greenbrook TMS (NASDAQ:GBNH) Trading Down 1.9%

Greenbrook TMS Inc. (NASDAQ:GBNHGet Free Report)’s share price fell 1.9% on Wednesday . The stock traded as low as $0.25 and last traded at $0.26. 182,071 shares were traded during mid-day trading, a decline of 57% from the average session volume of 426,648 shares. The stock had previously closed at $0.26.

Analysts Set New Price Targets

Separately, Bloom Burton lowered shares of Greenbrook TMS from an “accumulate” rating to a “hold” rating in a research note on Friday, November 10th.

Get Our Latest Report on Greenbrook TMS

Greenbrook TMS Price Performance

The firm has a 50-day simple moving average of $0.26 and a two-hundred day simple moving average of $0.35.

Greenbrook TMS (NASDAQ:GBNHGet Free Report) last announced its quarterly earnings results on Wednesday, November 8th. The company reported ($0.22) earnings per share (EPS) for the quarter. The firm had revenue of $18.04 million during the quarter, compared to analyst estimates of $19.50 million. Sell-side analysts anticipate that Greenbrook TMS Inc. will post -1.37 earnings per share for the current year.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently modified their holdings of GBNH. Madryn Asset Management LP acquired a new position in Greenbrook TMS during the first quarter worth $6,014,000. Masters Capital Management LLC raised its stake in shares of Greenbrook TMS by 389.6% in the 1st quarter. Masters Capital Management LLC now owns 3,427,272 shares of the company’s stock valued at $3,239,000 after acquiring an additional 2,727,272 shares in the last quarter. AdvisorShares Investments LLC lifted its holdings in Greenbrook TMS by 60.2% in the 3rd quarter. AdvisorShares Investments LLC now owns 416,923 shares of the company’s stock worth $108,000 after purchasing an additional 156,616 shares during the last quarter. Bank of Montreal Can bought a new stake in Greenbrook TMS during the first quarter worth approximately $123,000. Finally, UBS Group AG grew its holdings in Greenbrook TMS by 366.5% during the fourth quarter. UBS Group AG now owns 17,668 shares of the company’s stock valued at $34,000 after purchasing an additional 13,881 shares during the last quarter. Institutional investors own 64.29% of the company’s stock.

About Greenbrook TMS

(Get Free Report)

Greenbrook TMS Inc, together with its subsidiaries, controls and operates a network of outpatient mental health services centers in the United States. Its centers specialize in the provision of transcranial magnetic stimulation (TMS) therapy, an FDA-cleared non-invasive therapy for the treatment of major depressive disorder and other mental health disorders, as well as related psychiatric services.

Further Reading

Receive News & Ratings for Greenbrook TMS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Greenbrook TMS and related companies with's FREE daily email newsletter.